hematopoietic system
• increased cellularity in spleen
• frequencies of T and B cells in spleen normal
|
• shift to higher levels of surface IgM and CD21
• antigen responses decreased or absent
• Th1 type antibody response more affected than Th2 type response
• lower responses to B cell activating stimuli
• B cell responses selectively impaired
|
• peritoneal B1 cells are nearly absent but B2 cells unaffected
|
• 90% reduction in IgG3 levels in serum
• overall IgG levels about normal
|
• 50% decrease in IgM levels in serum
|
• high serum levels develop with age
|
• defective CD28 costimulation of T cells but T cell activation otherwise normal
|
immune system
• increased cellularity in spleen
• frequencies of T and B cells in spleen normal
|
• shift to higher levels of surface IgM and CD21
• antigen responses decreased or absent
• Th1 type antibody response more affected than Th2 type response
• lower responses to B cell activating stimuli
• B cell responses selectively impaired
|
• peritoneal B1 cells are nearly absent but B2 cells unaffected
|
• increased cellularity in lymph nodes
• frequencies of T and B cells in lymph nodes normal
|
• 90% reduction in IgG3 levels in serum
• overall IgG levels about normal
|
• 50% decrease in IgM levels in serum
|
• high serum levels develop with age
|
• defective CD28 costimulation of T cells but T cell activation otherwise normal
|
• teary eyes
|
dermatitis
(
J:84042
)
• dermatitis develops on ears and neck
• hyperkeratosis of inflamed regions of skin
|
erythroderma
(
J:84042
)
• erythematous ears at 10-20 weeks
• become intensely itchy
|
integument
dermatitis
(
J:84042
)
• dermatitis develops on ears and neck
• hyperkeratosis of inflamed regions of skin
|
erythroderma
(
J:84042
)
• erythematous ears at 10-20 weeks
• become intensely itchy
|
growth/size/body
• increased cellularity in spleen
• frequencies of T and B cells in spleen normal
|